Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;14(12):963-975.
doi: 10.1038/cmi.2017.88. Epub 2017 Sep 11.

Innate immunity in tuberculosis: host defense vs pathogen evasion

Affiliations
Review

Innate immunity in tuberculosis: host defense vs pathogen evasion

Cui Hua Liu et al. Cell Mol Immunol. 2017 Dec.

Abstract

The major innate immune cell types involved in tuberculosis (TB) infection are macrophages, dendritic cells (DCs), neutrophils and natural killer (NK) cells. These immune cells recognize the TB-causing pathogen Mycobacterium tuberculosis (Mtb) through various pattern recognition receptors (PRRs), including but not limited to Toll-like receptors (TLRs), Nod-like receptors (NLRs) and C-type lectin receptors (CLRs). Upon infection by Mtb, the host orchestrates multiple signaling cascades via the PRRs to launch a variety of innate immune defense functions such as phagocytosis, autophagy, apoptosis and inflammasome activation. In contrast, Mtb utilizes numerous exquisite strategies to evade or circumvent host innate immunity. Here we discuss recent research on major host innate immune cells, PRR signaling, and the cellular functions involved in Mtb infection, with a specific focus on the host's innate immune defense and Mtb immune evasion. A better understanding of the molecular mechanisms underlying host-pathogen interactions could provide a rational basis for the development of effective anti-TB therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Major host immune cells, pattern recognition receptors and cellular functions involved in innate immune defense against Mtb. Mtb mainly infects innate immune cells, including macrophages, dendritic cells, neutrophils and natural killer cells. Those immune cells recognize Mtb through various pattern recognition receptors, including Toll-like receptors (such as TLR1, TLR2, TLR4, TLR7, TLR8 and TLR9), Nod-like receptors (such as NOD1, NOD2, NLRP3 and NLRC4) and C-type lectin receptors (such as MR, DC-SIGN, Mincle, Dectin-1 and Dectin-2, Dectin-3, CL-LK and DCIR). During Mtb infection, the host orchestrates signaling from those PRRs and launches a variety of cellular functions, such as phagocytosis, autophagy, apoptosis and inflammasome activation, to control or eliminate Mtb.
Figure 2
Figure 2
Mtb components interfering with host cellular functions. During Mtb infection, multiple Mtb components interfere (either activate or inhibit) with host cellular functions (such as phagocytosis, autophagy, apoptosis and inflammasome activation) to help the pathogen evade or circumvent host innate immunity. For example, PPE57 promotes phagocytosis, whereas PIMs, ManLAM, PknG, PtpA and EIS inhibit the complete phagocytosis of macrophages through arresting phagosome maturation; ESAT-6 and C-di-AMP activate, whereas EIS, SapM, LrpG and PDIM inhibit autophagy. Many Mtb components can either activate (including LpqH, PE_PGRS33, ESAT-6, OppD, PstS1, Rv0183, Rv0901, PE9/PE10 and Mce4A) or inhibit (including PtpA, NuoG, PknE, SecA2, SodA, SigH, MPT64 and Rv3354) apoptosis; EsxA and Mtb DNA can activate, whereas Zmp1 can inhibit inflammasome activation.

References

    1. World Health Organization. Global Tuberculosis Report 2016. WHO: Geneva, Switzerland, 2016.
    1. Sia JK, Georgieva M, Rengarajan J. Innate immune defenses in human tuberculosis: an overview of the interactions between mycobacterium tuberculosis and innate immune cells. J Immunol Res 2015; 2015: 747543. - PMC - PubMed
    1. Killick KE, Ni Cheallaigh C, O'Farrelly C, Hokamp K, MacHugh DE, Harris J. Receptor-mediated recognition of mycobacterial pathogens. Cell Microbiol 2013; 15: 1484–1495. - PubMed
    1. Lerner TR, Borel S, Gutierrez MG. The innate immune response in human tuberculosis. Cell Microbiol 2015; 17: 1277–1285. - PMC - PubMed
    1. Khan N, Vidyarthi A, Javed S, Agrewala JN. Innate immunity holding the flanks until reinforced by adaptive immunity against mycobacterium tuberculosis infection. Front Microbiol 2016; 7: 328. - PMC - PubMed

Substances